Non-biotinylated Human CD30/TNFRSF8 Protein, Ultra Low Endotoxin (CD3-HM430-UL)
  • Express System: HEK293
  • Product Tag: C-His-Avi
  • Purity: > 95% as determined by Bis-Tris PAGE;> 90% as determined by HPLC
  • Activity: Immobilized Human CD30, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Human CD30 Ligand, mFc Tag with the EC50 of 21.4ng/ml determined by ELISA.
  • Amino Acid Range: Phe19-Lys379
Catalog #CD3-HM430-UL
Regular price $223.30
/
Size
image image

Order by 4pm ET for delivery on:

Non-biotinylated Human CD30/TNFRSF8 Protein, Ultra Low Endotoxin (CD3-HM430-UL) Summary

Product Description

Recombinant Human CD30/TNFRSF8 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Phe19-Lys379.

Product Background

The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153, TNFSF8) are members of the tumor necrosis factor (TNF) superfamily and display restricted expression in subpopulations of activated T-and B-cells in nonpathologic conditions. CD30 expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs).

Product Category

Recombinant Protein / Antibody discovery / CAR-T targets, ADC targets

Non-biotinylated Human CD30/TNFRSF8 Protein, Ultra Low Endotoxin (CD3-HM430-UL) Specifications/Details

Protein
CD30/TNFRSF8
Synonyms
CD30; CD30KI-1; CD30L receptor; TNFRSF8; D1S166EKi-1; CD30KI-1
Accession
Species
Human
Biotinylated
no
Amino Acid Range
Phe19-Lys379
Molecular Weight
The protein has a predicted MW of 41.3 kDa. Due to glycosylation, the protein migrates to 68-95 kDa based on Bis-Tris PAGE result.
Activity
Immobilized Human CD30, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Human CD30 Ligand, mFc Tag with the EC50 of 21.4ng/ml determined by ELISA.
Product Tag
C-His-Avi

Fluorophore

Unconjugated
Expression System
HEK293
Purity
> 95% as determined by Bis-Tris PAGE;> 90% as determined by HPLC
Endotoxin
Less than 0.01 EU per ug by the LAL method.

Shipping, Reconstitution, & Storage

Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 ug or less, at 1mg/ml for 500ug or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Stability And Storage
-20 to -80°C for 12 months as supplied from date of receipt.;-80°C for 3 months after reconstitution.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Validation Images

Immobilized Human CD30, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Human CD30 Ligand, mFc Tag with the EC50 of 21.4ng/ml determined by ELISA. Immobilized Human CD30, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Human CD30 Ligand, mFc Tag with the EC50 of 21.4ng/ml determined by ELISA.
Immobilized Human CD30, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-CD30 Antibody, hFc Tag with the EC50 of 2.8ng/ml determined by ELISA. Immobilized Human CD30, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-CD30 Antibody, hFc Tag with the EC50 of 2.8ng/ml determined by ELISA.
Human CD30 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Human CD30 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human CD30 is greater than 90% as determined by SEC-HPLC. The purity of Human CD30 is greater than 90% as determined by SEC-HPLC.
Other Available Proteins:
Finding available proteins...
Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Recommended Products

Loading...
Recently viewed